Achaogen wins CARB-X funding award to advance development of novel aminoglycoside
Achaogen announced it has entered into an award agreement with CARB-X. Under the agreement, Achaogen will receive an initial award of up to $2.4 million, with the possibility of up to $9.6 million more from CARB-X at its discretion based on the achievement of certain project milestones. April 26, 2018